Compare KOD & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOD | WOLF |
|---|---|---|
| Founded | 2009 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 838.3M |
| IPO Year | 2018 | 1993 |
| Metric | KOD | WOLF |
|---|---|---|
| Price | $26.05 | $18.98 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | ★ $26.57 | $10.50 |
| AVG Volume (30 Days) | ★ 1.1M | 960.4K |
| Earning Date | 11-13-2025 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $759,700,000.00 |
| Revenue This Year | N/A | $8.53 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.92 | $8.05 |
| 52 Week High | $31.18 | $36.60 |
| Indicator | KOD | WOLF |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 48.92 |
| Support Level | $23.92 | $16.75 |
| Resistance Level | $28.11 | $19.98 |
| Average True Range (ATR) | 2.28 | 1.01 |
| MACD | -0.49 | 0.24 |
| Stochastic Oscillator | 27.41 | 64.86 |
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.